It is used for the preparation of amide-substituted xanthine derivatives as phosphoenolpyruvate carboxykinase inhibitors with gluconeogenesis modulating activity for treating type 2 diabetes.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.